Will they sell the intellectual rights to the highest bidder?
That makes absolutely no sense to me from a financial standpoint. Why would they want to kill their own shares? It would be logical that they ultimately sell their controlling interest. At what price and to who is the question? And at what point? You've got to think they want the inhaler trials fully approved and distribution ongoing throughout Europe and North America. These are steps that are at minimum many months away. I think we need to worry about getting an FDA EUA and many other items before we start dissecting GEM's long-term intentions. If things go like we hope with Aviptadil there will be plenty of opportunities to hop off the train with gains along the way.
News 
Market Data 
Discover 
